91807-59-9 Usage
Uses
As the precise applications and effects of (S)-N-(2,5-dioxotetrahydrofuran-3-yl)-2-phenoxyacetamide are still being studied, its uses are not yet fully established. However, given its potential therapeutic properties, it may be used in the following ways:
Used in Pharmaceutical Research:
(S)-N-(2,5-dioxotetrahydrofuran-3-yl)-2-phenoxyacetamide is used as a research compound for exploring its potential therapeutic properties and applications in the development of new medications.
Used in Medicinal Chemistry:
(S)-N-(2,5-dioxotetrahydrofuran-3-yl)-2-phenoxyacetamide is used as a building block or a starting material in the synthesis of new pharmaceutical agents, potentially leading to the discovery of novel drugs with improved efficacy and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 91807-59-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,8,0 and 7 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 91807-59:
(7*9)+(6*1)+(5*8)+(4*0)+(3*7)+(2*5)+(1*9)=149
149 % 10 = 9
So 91807-59-9 is a valid CAS Registry Number.
InChI:InChI=1/C13H14N2O4/c1-15-11(16)7-10(12(15)17)14-13(18)19-8-9-5-3-2-4-6-9/h2-6,10H,7-8H2,1H3,(H,14,18)
91807-59-9Relevant academic research and scientific papers
Synthesis and evaluation of anti-apoptotic activity of L-carnitine cyclic analogues and amino acid derivatives
Fringuelli, Renata,Utrilla Navarro, M. Pilar,Milanese, Lara,Bruscoli, Stefano,Schiaffella, Fausto,Riccardi, Carlo,De Simone, Claudio
, p. 271 - 277 (2007/10/03)
Two series of derivatives were synthesised. In one series (R)-4-hydroxy-2-pyrrolidinone was used as a mimic of cyclic L-carnitine analogue and in the second series 3-amino-2-piperidinone was used as a cyclic ornithine analogue. N-Benzyloxycarbonyl derivatives of some amino acids were also prepared. The newly synthesised compounds were tested for their ability to inhibit Fas-activated apoptosis of human Jurkatt T-cell line. The results confirm the previously described anti-apoptotic activity of carnitine and indicate new carnitine and amino acid analogues (1, 3, 6, 7, 20) that inhibit Fas-induced apoptosis.
